ClinicalTrials.gov
public full text
Public Domain
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
To determine the safety and efficacy of SEP-225441 (eszopiclone) in subjects with generalized anxiety disorder (GAD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults#448312
- A Dose-Response Safety Study of ENX-102 in Patients With GAD#1010253
- A Study of ENX-104 in Healthy Participants#1059153
- A Study of JR-141 in Patients With Mucopolysaccharidosis Type II#1033058
- Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953#1152809
Record · ID 903886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive